STCube News
News
0
Ticker
052020.KQ
ISIN
KR7052020005
STCube Eulerpool News
STCube Stock News
STCube is being monitored by journalists and investors worldwide. We gather the latest STCube news here.
STCube Stock Press Releases
STCube regularly publishes news on the company's website that are relevant for investors.
STCube News 2026
This page contains all current news, analysis and press releases for STCube stock (052020.KQ, ISIN: KR7052020005). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at STCube.
STCube Stock
STCube STCube Inc. generates revenue through its two business segments. The IT segment distributes CCTV lenses and related components, targeting businesses requiring security solutions. The BT segment develops and licenses immunomodulatory anticancer drug therapeutic candidates, selling to pharmaceutical companies and research institutions. Both segments operate under the company's brand, leveraging its IT and biotechnology expertise. The IT segment focuses on closed-circuit television lens distribution, serving commercial and industrial clients seeking reliable security infrastructure. The BT segment's drug development and licensing activities cater to the pharmaceutical industry, providing innovative therapeutic candidates for cancer treatment. These offerings align with STCube's dual expertise in technology and biotechnology. STCube's revenue streams are derived from product distribution in the IT sector and licensing agreements in the biotechnology sector. The company's clients include businesses needing CCTV components and pharmaceutical firms interested in anticancer drug development. This dual approach allows STCube to serve distinct market segments with specialized solutions.